Aktie A1C63S MEDICAL MARIJUANA, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Medical Marijuana, Inc.

Aktien

A1C63S

US58463A1051

MJNA

Verzögert OTC Markets
Andere Börsenplätze
 18:07:16 26.04.2024 		% 5 Tage % 1. Jan.
0,0019 USD -5,00 % Intraday Chart für Medical Marijuana, Inc. -9,52 % -48,65 %
2023 Medical Marijuana, Inc. (OTCPK:MJNA) hat im Wesentlichen das gesamte Betriebsvermögen von KZ1 für 5 Millionen Dollar erworben. CI
2023 Medizinisches Marihuana, Inc. kündigt Änderungen in der Geschäftsführung an CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Thinking about buying stock in Inpixon, Medical Marijuana, Hello Group, Vroom, or Heritage Insurance Holdings?
AXIM Biotechnologies, Inc. announced that it expects to receive $0.75 million in funding from Medical Marijuana, Inc.
Medical Marijuana, Inc. acquired Essentially all Operating Assets of KZ1 for $5 million.
Medical Marijuana, Inc. Announces Executive Changes
Medical Marijuana, Inc. Appoints Dr. Timothy R. Scott as Its New Chief Executive Officer
Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
Medical Marijuana, Inc. Participates in Preclinical Research Study on Therapeutic Benefits of CBD on Traumatic Brain Injuries
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
Medical Marijuana, Inc. Reports $4.9 Million in Net Revenue in 2022 Third Quarter Financial and Operational Results
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Celebrates Successful Sponsorship of 2022 XII Latin American Congress of Epilepsy in Medellin, Colombia
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson's Disease Treatment
Medical Marijuana, Inc. Enters Into Asset Purchase Agreement With MFINITY Global LLC; Appoints MFINITY President as Kannaway President
Medical Marijuana, Inc. Signs Deal With Leading European Manufacturer and Distributor to Expand Channel Access to Products Throughout the Region
Medical Marijuana, Inc. Reports $7.8 Million in Net Revenue in 2022 Second Quarter Financial and Operational Results
Medical Marijuana, Inc. Subsidiary HM Pharma Submits CBD Product Dossier; Receives Sanitary Registration in Brazil
GRN Holdings Corporation, Inc. (OTC: GRNF) Announces Name Change to Marijuana Inc., New Management and Business Model
Medical Marijuana, Inc. CEO Provides Insight on Future of U.S. Cannabis Market in Nasdaq News
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Health & Wellness Podcast; Secures Features in Top Brazil Lifestyle Publications
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1C63S Aktie
  4. Nachrichten Medical Marijuana, Inc.
  5. Andere Sprachen